These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 34088416)

  • 21. [Diagnostics and treatment of giant cell arteritis].
    Kraemer M; Becker J; Bley TA; Steinbrecher A; Minnerup J; Hellmich B
    Nervenarzt; 2022 Aug; 93(8):819-827. PubMed ID: 34734295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glucocorticoids for Management of Polymyalgia Rheumatica and Giant Cell Arteritis.
    Matteson EL; Buttgereit F; Dejaco C; Dasgupta B
    Rheum Dis Clin North Am; 2016 Feb; 42(1):75-90, viii. PubMed ID: 26611552
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunosuppressive treatment for giant cell arteritis: where do we stand?
    Pipitone N; Salvarani C
    Clin Exp Rheumatol; 2015; 33(2 Suppl 89):S-5-6. PubMed ID: 26016749
    [No Abstract]   [Full Text] [Related]  

  • 24. Resolution of vascular inflammation in patients with new-onset giant cell arteritis: data from the RIGA study.
    Schönau V; Roth J; Tascilar K; Corte G; Manger B; Rech J; Schmidt D; Cavallaro A; Uder M; Crescentini F; Boiardi L; Casali M; Spaggiari L; Galli E; Kuwert T; Versari A; Salvarani C; Schett G; Muratore F
    Rheumatology (Oxford); 2021 Aug; 60(8):3851-3861. PubMed ID: 33831144
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Giant cell arteritis: diagnosing and treating inflammatory disease in older adults.
    Azhar SS; Tang RA; Dorotheo EU
    Geriatrics; 2005 Aug; 60(8):26-30. PubMed ID: 16092890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monitoring and long-term management of giant cell arteritis and polymyalgia rheumatica.
    Camellino D; Matteson EL; Buttgereit F; Dejaco C
    Nat Rev Rheumatol; 2020 Sep; 16(9):481-495. PubMed ID: 32759996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Primary Care Vasculitis: Polymyalgia Rheumatica and Giant Cell Arteritis.
    Pioro MH
    Prim Care; 2018 Jun; 45(2):305-323. PubMed ID: 29759126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. New developments in giant cell arteritis.
    Frohman L; Wong AB; Matheos K; Leon-Alvarado LG; Danesh-Meyer HV
    Surv Ophthalmol; 2016; 61(4):400-21. PubMed ID: 26774550
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitative ultrasound to monitor the vascular response to tocilizumab in giant cell arteritis.
    Seitz L; Christ L; Lötscher F; Scholz G; Sarbu AC; Bütikofer L; Kollert F; Schmidt WA; Reichenbach S; Villiger PM
    Rheumatology (Oxford); 2021 Nov; 60(11):5052-5059. PubMed ID: 34117737
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biologic treatment of large-vessel vasculitides.
    Schäfer VS; Zwerina J
    Curr Opin Rheumatol; 2012 Jan; 24(1):31-7. PubMed ID: 22089099
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [From pathogenesis of giant cell arteritis to new therapeutic targets].
    Samson M; Bonnotte B
    Rev Med Interne; 2017 Oct; 38(10):670-678. PubMed ID: 28800947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Large-vessel giant cell arteritis: diagnosis, monitoring and management.
    Koster MJ; Matteson EL; Warrington KJ
    Rheumatology (Oxford); 2018 Feb; 57(suppl_2):ii32-ii42. PubMed ID: 29982778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tocilizumab for giant cell arteritis: an amazing result.
    Işık M; Kılıç L; Doğan İ; Calgüneri M
    Rheumatol Int; 2013 Nov; 33(11):2961-2. PubMed ID: 22965672
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocilizumab in giant cell arteritis: an update for the clinician.
    Ford JA; Gewurz D; Gewurz-Singer O
    Curr Opin Rheumatol; 2023 May; 35(3):135-140. PubMed ID: 36912060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Giant Cell Arteritis: Beyond Corticosteroids.
    Steel L; Khan A; Dasgupta B
    Drugs Aging; 2015 Aug; 32(8):591-9. PubMed ID: 26239828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [How to manage giant cell arteritis].
    Allali D; Blondon M; Roux-Lombard P; Spoerl D
    Rev Med Suisse; 2020 Jan; 16(676-7):12-15. PubMed ID: 31961075
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recent advances in the diagnosis and management of giant cell arteritis.
    Serling-Boyd N; Stone JH
    Curr Opin Rheumatol; 2020 May; 32(3):201-207. PubMed ID: 32168069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tocilizumab in Giant Cell Arteritis: A Real-Life Retrospective Study.
    Vitiello G; Orsi Battaglini C; Carli G; Radice A; Matucci A; Vultaggio A; Olianti C; Parronchi P; Maggi E; Cammelli D
    Angiology; 2018 Oct; 69(9):763-769. PubMed ID: 29343075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Giant cell arteritis and innovative treatments.
    Costanzo G; Ledda AG; Sambugaro G
    Curr Opin Allergy Clin Immunol; 2023 Aug; 23(4):327-333. PubMed ID: 37357797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A severe cerebral infarction associated with giant cell arteritis, which developed during tocilizumab therapy and was successfully treated with intravenous cyclophosphamide.
    Suzuki K; Akiyama M; Ishigaki S; Kondo Y; Saito S; Kikuchi J; Hanaoka H; Kaneko Y
    Mod Rheumatol Case Rep; 2023 Jun; 7(2):453-457. PubMed ID: 36715093
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.